Optimizing [(212)Pb]Pb-AB001 Radiopharmaceutical Therapy Schedules in PSMA-Positive Subcutaneous Prostate Cancer Xenografts. Hoyvik AJK, Stenberg VY, Liukaityte R, Repetto-Llamazares A, et al. J Nucl Med 2025 Oct 3:jnumed.125.270444. doi: 10.2967/jnumed.125.270444.

Read + Share

Amedeo Smart

Independent Medical Education

Hoyvik AJK, Stenberg VY, Liukaityte R, Repetto-Llamazares A, et al. Optimizing [(212)Pb]Pb-AB001 Radiopharmaceutical Therapy Schedules in PSMA-Positive Subcutaneous Prostate Cancer Xenografts. J Nucl Med 2025 Oct 3:jnumed.125.270444. doi: 10.2967/jnumed.125.270444.
PMID: 41043994